$14.90
0.050.34%
al cierre: Nov 13, 4:00 PM EST
$14.90
N/A
After hour: 4:00 PM EST
HUTCHMED (China) fell 1.2% from $15.08 to $14.90, behind the S&P 500's +12.3%. Its worst day was Jul 17 (−6.6%), and its low came Jun 22 at $9.99.
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
— Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease —
+6.6% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
HUTCHMED (China) closed at its highest level of the year, 6.4% above where the year started.
+4.8% · S&P 500 −0.1%
EPS of $2.62 beat the $1.43 estimate on $548.5M revenue (est. $591.4M).
+1.5% · S&P 500 −0.6%
HUTCHMED (China) closed at its lowest level of the year, 33.8% below where the year started.
−2.8% · S&P 500 −0.3%
HUTCHMED (China) shares fell 6.6%, while the S&P 500 fell 1.0%.
−6.6%, the year's worst day · S&P 500 −1.0%
EPS of $0.09 was reported on $278.3M revenue.
−5.4% · S&P 500 +1.7%
HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; HKEX: 13) today announces that its subsidiary, HUTCHMED Limited, has entered into an exclusive development and license agreement with a subsidiary of GSK
+17.2%, the year's best day, on 512K shares, the year's heaviest volume · S&P 500 +1.0%
HUTCHMED (China) shares rose 6.6%, while the S&P 500 fell 0.4%.
+6.6% · S&P 500 −0.4%
HUTCHMED (China) shares rose 6.8%, while the S&P 500 rose 0.3%.
+6.8% · S&P 500 +0.3%
Where it ended: a close of $14.90 on Nov 13, 2026. Up next: FY 2026 earnings on Mar 4, 2027 (EPS est. $0.22, revenue est. $620.5M).
Nothing in the past 12 months.
All HCM dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HCM and SPY from Benzinga historical bars. Not investment advice.